MyndTec garners investment towards MyndMove Therapy
Regulations & Standards
Award-winning medical technology OEM MyndTec, Mississauga ON, has received $510(k) clearance to market its landmark product MyndMove. MyndTec is a pioneer in the treatment of arm and hand paralysis caused by stroke or spinal cord injury.
“This is a major milestone in the evolution of our company,” says MyndTec founder Dr. Milos R. Popovic. “We are delighted that we can now offer this life-changing therapy to patients in the U.S. with upper extremity paralysis.”
MyndTec intends to initiate a pilot launch of MyndMove into the U.S. market which complements a product introduction already underway in Canada with a previously announced approval from Health Canada. MyndMove Therapy is a functional electric stimulation (FES) based intervention that provides therapists the ability to assist individuals with upper limb paralysis to improve voluntary control of their arms and hands. The MyndMove system provides more than 30 FES protocols that therapists use to enable meaningful controlled movements via proprietary stimulation technology.
MyndTec is a privately held medical technology firm that develops and commercializes therapeutic medical devices designed to improve function, maximize independence and enhance quality of life. MyndTec was founded in 2008 as Simple Systems Inc., to commercialize technology developed by Dr. Milos R. Popovic and his colleagues at the Toronto Rehabilitation Institute-University Health Network and the Institute of Biomaterials and Biomedical Engineering at the University of Toronto.